FDA moves toward easing restrictions on certain peptides BioPharma Dive The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Peptide Boom Is Getting Out of Hand The Atlantic Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review The trend of unproven peptides is spreading through influencers and RFK Jr. allies CNN BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with